EZZ Life Science Holdings Ltd (EZZ) — Capital Reinvestment Ratio

Latest as of June 2025: 0.02x

EZZ Life Science Holdings Ltd (EZZ) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow (AU$2.86 Million) in capital expenditures (AU$48.35K). See EZZ Life Science Holdings Ltd net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

AU$2.86 Million
AUD

Capital Expenditures

AU$48.35K
AUD

Data as of

Jun 2025
Most recent filing

EZZ Life Science Holdings Ltd Capital Reinvestment Ratio (2018–2024)

This chart tracks EZZ Life Science Holdings Ltd's Capital Reinvestment Ratio across 7 annual periods. Check EZZ Life Science Holdings Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for EZZ Life Science Holdings Ltd (2018–2024)

Year-by-year Capital Reinvestment Ratio for EZZ Life Science Holdings Ltd from 2018 to 2024. For live market cap and broader valuation context, see EZZ Life Science Holdings Ltd (EZZ) market capitalisation.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2024 0.06x AU$4.35 Million AU$260.88K ▼ -10.0%
2023 0.07x AU$6.14 Million AU$409.29K ▲ +162.7%
2022 0.03x AU$4.01 Million AU$101.78K ▲ +266.0%
2021 0.01x AU$1.90 Million AU$13.18K ▼ -89.1%
2020 0.06x AU$253.53K AU$16.12K ▲ +107.3%
2019 0.03x AU$2.97 Million AU$91.20K ▲ +402.0%
2018 0.01x AU$416.33K AU$2.54K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow